BIOMAT Database Logo BIOMAT Database Logo

Therapeutic drug monitoring for mycophenolic acid in patients with autoimmune diseases. 2008

Brenda C M de Winter, and Teun van Gelder

UI MeSH Term Description Entries
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D014657 Vasculitis Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. Angiitis,Angiitides,Vasculitides
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

Brenda C M de Winter, and Teun van Gelder
Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.
January 2010, European journal of dermatology : EJD,
Brenda C M de Winter, and Teun van Gelder
Therapeutic Drug Monitoring of Mycophenolic Acid.
January 2016, Advances in clinical chemistry,
Brenda C M de Winter, and Teun van Gelder
Therapeutic drug monitoring of mycophenolic acid.
September 2007, Clinical journal of the American Society of Nephrology : CJASN,
Brenda C M de Winter, and Teun van Gelder
Scientific principles for mycophenolic acid therapeutic drug monitoring.
August 1998, Transplantation proceedings,
Brenda C M de Winter, and Teun van Gelder
Therapeutic drug monitoring for mycophenolic acid is value for (little) money.
August 2011, Clinical pharmacology and therapeutics,
Brenda C M de Winter, and Teun van Gelder
Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
July 1998, Clinical biochemistry,
Brenda C M de Winter, and Teun van Gelder
Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients.
March 2005, Transplantation proceedings,
Brenda C M de Winter, and Teun van Gelder
Therapeutic monitoring of mycophenolic acid in liver transplant patients.
April 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Brenda C M de Winter, and Teun van Gelder
Therapeutic drug monitoring of mycophenolic acid: a potential treatment for lupus nephritis.
August 2010, Kidney international,
Brenda C M de Winter, and Teun van Gelder
Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid.
January 2006, Journal of postgraduate medicine,
Copied contents to your clipboard!